Skip to content

Feasibility study for dexmedetomidine combined with target-controlled infusion of remifentanil in reducing the incidence of hypoxemia during endoscopic retrograde cholangio pancreatography of elderly patients

Feasibility study for dexmedetomidine combined with target-controlled infusion of remifentanil in reducing the incidence of hypoxemia during endoscopic retrograde cholangio pancreatography of elderly patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058413
Enrollment
Unknown
Registered
2022-04-09
Start date
2022-04-30
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive tract disease

Interventions

TRD Group:Dextromex was replaced with an equivalent dose of propofol
TRP Group: Propofolwas replaced with dextromex an equivalent dose of

Sponsors

General Hospital of Northern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged >65 years old; 2. ASA classification II~III; 3. BMI<30kg/m2; 4. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Excessive mental stress; 2. Severe cardiovascular, respiratory, neuropsychiatric and endocrine diseases; 3. A history of drug and alcohol dependence; 4. Difficult airway; 5. Patients with severe liver and kidney dysfunction, acute upper gastrointestinal bleeding with shock, severe anemia, mental illness, cognitive impairment, serious heart disease, coagulation disorder, nosebleed or other patients who cannot tolerate surgery; 6. Pneumothorax, COPD, abnormal upper respiratory tract (obstruction, severe stenosis); 7. Circulatory and respiratory diseases that may threaten life, such as uncontrolled severe hypertension, severe arrhythmia, unstable angina, acute respiratory infections, asthma attacks, etc.; 8. Other diseases causing hypoxia that could affect the study.

Design outcomes

Primary

MeasureTime frame
Oxygen saturation;

Secondary

MeasureTime frame
Mean arterial pressure;Bispectral Index;Heart rate;Respiratory rate;

Countries

China

Contacts

Public ContactSong Dandan

General Hospital of Northern Theater Command

chenning5205@163.com+86 17790993788

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026